{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:27:59Z","timestamp":1790216879993,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Novartis Gene Therapies, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12325-021-01938-w","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T13:03:51Z","timestamp":1635426231000},"page":"5809-5828","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis"],"prefix":"10.1007","volume":"38","author":[{"given":"Marjolaine","family":"Gauthier-Loiselle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Cloutier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Toro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Bischof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"LaMarca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Dabbous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,28]]},"reference":[{"key":"1938_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1750-1172-6-71","volume":"6","author":"A D\u2019Amico","year":"2011","unstructured":"D\u2019Amico A, Mercuri E, Tiziano FD, Bertini E. Spinal muscular atrophy. Orphanet J Rare Dis. 2011;6:71.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1938_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ejhg.2011.134","volume":"20","author":"EA Sugarman","year":"2012","unstructured":"Sugarman EA, Nagan N, Zhu H, et al. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens. Eur J Hum Genet. 2012;20(1):27\u201332.","journal-title":"Eur J Hum Genet"},{"key":"1938_CR3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrn2670","volume":"10","author":"AH Burghes","year":"2009","unstructured":"Burghes AH, Beattie CE. Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Nat Rev Neurosci. 2009;10:597\u2013609.","journal-title":"Nat Rev Neurosci"},{"key":"1938_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/338627","volume":"70","author":"M Feldk\u00f6tter","year":"2002","unstructured":"Feldk\u00f6tter M, Schwarzer V, Wirth R, Wienker TF, Wirth B. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet. 2002;70:358\u201368.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1938_CR5","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","volume":"82","author":"Y Hua","year":"2008","unstructured":"Hua Y, Vickers TA, Okunola HL, Bennett CF, Krainer AR. Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice. Am J Hum Genet. 2008;82(4):834\u201348.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1938_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/dmcn.14027","volume":"61","author":"T Gidaro","year":"2019","unstructured":"Gidaro T, Servais L. Nusinersen treatment of spinal muscular atrophy: current knowledge and existing gaps. Dev Med Child Neurol. 2019;61(1):19\u201324.","journal-title":"Dev Med Child Neurol"},{"issue":"7","key":"1938_CR7","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1710504","volume":"378","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Darras BT, Chiriboga CA, et al. Nusinersen versus sham control in later-onset spinal muscular atrophy. N Engl J Med. 2018;378(7):625\u201335.","journal-title":"N Engl J Med"},{"issue":"18","key":"1938_CR8","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT, et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017;377(18):1723\u201332.","journal-title":"N Engl J Med"},{"key":"1938_CR9","unstructured":"Spinraza (nusinersen) [presecribing information]. Cambridge MA; Biogen. 2020."},{"issue":"7","key":"1938_CR10","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1177\/0883073815627882","volume":"31","author":"M Hach\u00e9","year":"2016","unstructured":"Hach\u00e9 M, Swoboda KJ, Sethna N, Farrow-Gillespie A, Khandji A, Xia S, et al. Intrathecal injections in children with spinal muscular atrophy: nusinersen clinical trial experience. J Child Neurol. 2016;31(7):899\u2013906.","journal-title":"J Child Neurol"},{"issue":"5","key":"1938_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487\u201397.","journal-title":"N Engl J Med"},{"issue":"2","key":"1938_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1542\/peds.2013-3225","volume":"134","author":"V Ivanovska","year":"2014","unstructured":"Ivanovska V, Rademaker CM, van Dijk L, Mantel-Teeuwisse AK. Pediatric drug formulations: a review of challenges and progress. Pediatrics. 2014;134(2):361\u201372.","journal-title":"Pediatrics"},{"issue":"2","key":"1938_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/17476348.2017.1280399","volume":"11","author":"S Narayanan","year":"2017","unstructured":"Narayanan S, Mainz JG, Gala S, Tabori H, Grossoehme D. Adherence to therapies in cystic fibrosis: a targeted literature review. Expert Rev Respir Med. 2017;11(2):129\u201345.","journal-title":"Expert Rev Respir Med"},{"issue":"3","key":"1938_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5001\/omj.2011.38","volume":"26","author":"B Jimmy","year":"2011","unstructured":"Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26(3):155\u20139.","journal-title":"Oman Med J"},{"issue":"3","key":"1938_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1108\/IJHCQA-03-2016-0033","volume":"30","author":"V Dalvi","year":"2017","unstructured":"Dalvi V, Mekoth N. Patient non-adherence: an interpretative phenomenological analysis. Int J Health Care Qual Assur. 2017;30(3):274\u201384.","journal-title":"Int J Health Care Qual Assur"},{"issue":"9","key":"1938_CR16","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1080\/03007995.2018.1477747","volume":"34","author":"CA Forbes","year":"2018","unstructured":"Forbes CA, Deshpande S, Sorio-Vilela F, et al. A systematic literature review comparing methods for the measurement of patient persistence and adherence. Curr Med Res Opin. 2018;34(9):1613\u201325.","journal-title":"Curr Med Res Opin"},{"key":"1938_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jclinepi.2017.07.011","volume":"91","author":"SS Allemann","year":"2017","unstructured":"Allemann SS, Nieuwlaat R, Navarro T, Haynes B, Hersberger KE, Arnet I. Congruence between patient characteristics and interventions may partly explain medication adherence intervention effectiveness: an analysis of 190 randomized controlled trials from a Cochrane systematic review. J Clin Epidemiol. 2017;91:70\u20139.","journal-title":"J Clin Epidemiol"},{"key":"1938_CR18","first-page":"35","volume":"7","author":"AO Iuga","year":"2014","unstructured":"Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7:35\u201344.","journal-title":"Risk Manag Healthc Policy"},{"issue":"1","key":"1938_CR19","doi-asserted-by":"publisher","first-page":"e016982","DOI":"10.1136\/bmjopen-2017-016982","volume":"8","author":"RL Cutler","year":"2018","unstructured":"Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8(1):e016982.","journal-title":"BMJ Open"},{"key":"1938_CR20","unstructured":"Symphony Health DataVerse\u00ae [Internet]. 2021. Available from: https:\/\/symphonyhealth.com\/product\/idv\/. Accessed 14 May 2021."},{"issue":"1","key":"1938_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/13696998.2019.1646263","volume":"23","author":"M Droege","year":"2020","unstructured":"Droege M, Sproule D, Arjunji R, Gauthier-Loiselle M, Cloutier M, Dabbous O. Economic burden of spinal muscular atrophy in the United States: a contemporary assessment. J Med Econ. 2020;23(1):70\u20139.","journal-title":"J Med Econ"},{"issue":"12-a Suppl","key":"1938_CR22","first-page":"S3","volume":"24","author":"VK Rao","year":"2018","unstructured":"Rao VK, Kapp D, Schroth M. Gene therapy for spinal muscular atrophy an emerging treatment option for a devastating disease. J Manag Care Spec Pharm. 2018;24(12-a Suppl):S3\u201316.","journal-title":"J Manag Care Spec Pharm"},{"key":"1938_CR23","unstructured":"Zolgensma (onasemnogene abeparvovec-xioi) [prescribing information]. Bannockburn, IL; AveXis Inc. 2021."},{"key":"1938_CR24","unstructured":"Food & Drug Administration. FDA approves oral treatment for spinal muscular atrophy. 2020. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-oral-treatment-spinal-muscular-atrophy. Accessed 10 June 2021."},{"key":"1938_CR25","unstructured":"Henry J. Kaiser Family Foundation Hospital Adjusted Expenses per Inpatient Day 2018 [January 17, 2019]. https:\/\/www.kff.org\/health-costs\/state-indicator\/expenses-per-inpatient-day. Accessed 14 May 2021."},{"issue":"4\u2013a Suppl","key":"1938_CR26","first-page":"S39","volume":"26","author":"E Chen","year":"2020","unstructured":"Chen E, To TM, Seetasith A, Tan A, Merida M, Iannaccone S. Nusinersen adherence among patients with spinal muscular atrophy (SMA) in the real world. J Manag Care Spec Pharm. 2020;26(4-a Suppl):S39\u201340.","journal-title":"J Manag Care Spec Pharm."},{"issue":"1","key":"1938_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ppul.25140","volume":"56","author":"M Lavie","year":"2021","unstructured":"Lavie M, Diamant N, Cahal M, Sadot E, Be\u2019er M, Fattal-Valevski A, et al. Nusinersen for spinal muscular atrophy type 1: real-world respiratory experience. Pediatr Pulmonol. 2021;56(1):291\u20138.","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"1938_CR28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/ENJ.ENJ_26_17","volume":"15","author":"KM Abdelhady","year":"2018","unstructured":"Abdelhady KM, El Samman GA, Attia AAM, Ahmed HAA. Factors affecting caregivers\u2019 adherence to therapeutic regimens for their children after kidney transplantation. Egypt Nurs J. 2018;15(1):79\u201392.","journal-title":"Egypt Nurs J"},{"issue":"5","key":"1938_CR29","first-page":"793","volume":"74","author":"P Gardiner","year":"2016","unstructured":"Gardiner P, Dvorkin L. Promoting medication adherence in children. Am Family Phys. 2016;74(5):793\u20138.","journal-title":"Am Family Phys"},{"issue":"1","key":"1938_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jcpt.12441","volume":"42","author":"XTW Goh","year":"2017","unstructured":"Goh XTW, Tan YB, Thirumoorthy T, Kwan YH. A systematic review of factors that influence treatment adherence in paediatric oncology patients. J Clin Pharm Therap. 2017;42(1):1\u20137.","journal-title":"J Clin Pharm Therap"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01938-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-021-01938-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01938-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T19:50:13Z","timestamp":1725997813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-021-01938-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,28]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1938"],"URL":"https:\/\/doi.org\/10.1007\/s12325-021-01938-w","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,28]]},"assertion":[{"value":"1 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}